Related by context. All words. (Click for frequent words.) 71 levodopa therapy 71 aromatase inhibitor therapy 71 heterozygous FH 71 diabetic kidney 70 neuropsychiatric symptoms 70 INVEGA ® 70 induce orthostatic hypotension 70 aminotransferases 70 VIIBRYD 70 hyperprolactinemia 70 AGILECT R 70 corticosteroid therapy 69 PAOD 69 proliferative diabetic retinopathy 69 Hypotension 69 neurocognitive deficits 69 neurologic symptoms 69 parkinsonian symptoms 69 extrapyramidal symptoms 69 Diabetic neuropathy 68 moderate renal impairment 68 EXJADE 68 OSAHS 68 bone marrow suppression 68 thrombotic complications 68 diabetic gastroparesis 68 autonomic dysfunction 68 intravitreal injections 68 comorbid depression 68 choroidal neovascularization 68 immunomodulatory therapy 68 TNF antagonist 68 renal toxicity 68 tardive dyskinesia TD 68 Critical limb ischemia 68 vertigo dizziness 68 idiopathic Parkinson disease 68 postoperative AF 68 trastuzumab Herceptin ® 68 HBeAg negative 68 hemodynamic instability 68 paroxysmal AF 68 opioid analgesia 67 hyperphenylalaninemia HPA due 67 SRBD 67 psychiatric comorbidity 67 recurrent glioblastoma multiforme 67 receiving XGEVA 67 erythema nodosum 67 severe renal impairment 67 QTc prolongation 67 TEAEs 67 extrapyramidal symptoms EPS 67 osteoarthritis rheumatoid arthritis 67 FROVA 67 myopathy rhabdomyolysis 67 rufinamide 67 cytopenias 67 antithrombotic therapy 67 lichen planus 67 artery stenosis 67 symptomatic hyponatremia 67 β blockers 67 systemic hypotension 67 primidone 67 Heavy menstrual bleeding 67 hematologic toxicity 67 morphometric vertebral fractures 67 psoriatic arthritis PsA 67 alpha interferons 67 corticosteroid dose 67 torsade de pointes 67 hereditary deficiency 67 proliferative retinopathy 67 ADPKD 67 lenalidomide dexamethasone 67 pyridostigmine 67 hypercalcemia 67 blepharospasm 67 systolic hypertension 67 NATRECOR ® 67 oxypurinol 67 multi infarct dementia 67 hemorrhagic cystitis 66 overt nephropathy 66 HER2 overexpression 66 VaD 66 PREZISTA r 66 thyrotoxicosis 66 orthostatic hypotension 66 anthracycline chemotherapy 66 immunosuppressive therapies 66 TMP SMX 66 elevated IOP 66 oxcarbazepine 66 hemorrhagic complications 66 androgen deprivation 66 glucocorticoid therapy 66 OAB symptoms 66 refractory angina 66 nonhematologic adverse reactions 66 oral anticoagulation 66 Torsades de Pointes 66 gemifloxacin 66 intravenous bisphosphonates 66 benign prostatic hypertrophy BPH 66 hypoxemia 66 NATRECOR R 66 allograft rejection 66 macroalbuminuria 66 prolonged QT interval 66 symptomatic paroxysmal AF 66 overactive bladder symptoms 66 myoclonus 66 haematologic 66 nephrotoxicity 66 inhaled glucocorticoids 66 Tardive dyskinesia 66 rheumatoid arthritis osteoarthritis ankylosing 66 vasomotor symptoms 66 pulmonary exacerbations 66 adrenal suppression 66 MIRAPEX ER 66 eosinophilic asthma 66 systemic corticosteroid 66 post thrombotic syndrome 66 chronic thromboembolic pulmonary 66 MIRAPEX 66 post herpetic neuralgia PHN 66 TMS Therapy 66 Hematologic 66 APTIVUS r 66 impaired cognition 66 syncope fainting 66 Postoperative complications 66 erlotinib Tarceva 66 therapeutic regimens 66 acute mania 66 pentoxifylline 66 Testosterone deficiency 66 antiepileptic medications 66 K ras mutations 66 renal insufficiency 66 interferon therapy 66 Chronic pancreatitis 66 recurrent DVT 66 postoperative morbidity 66 Adjuvant chemotherapy 66 kidney insufficiency 66 salmeterol fluticasone 66 refractory gout 66 GnRH agonists 66 antiplatelet medications 66 transaminase elevations 66 nasopharyngitis headache 66 antihypertensive therapy 66 CTEPH 66 Peripheral neuropathy 66 vasospasm 66 thromboembolic complications 66 antiarrhythmic drug 66 INVEGA ™ 65 squamous cell lung cancer 65 MAGE A3 ASCI 65 severe hypersensitivity reactions 65 lipid lowering agents 65 riociguat 65 Major Depressive Disorder MDD 65 Oral corticosteroids 65 unexplained syncope 65 headache abdominal pain 65 macrovascular complications 65 juvenile myoclonic epilepsy 65 metastatic neuroendocrine tumors 65 intermittent claudication 65 Fluid retention 65 rFVIIa 65 endocrine therapies 65 gastro esophageal reflux 65 CP CPPS 65 endometrial hyperplasia 65 constipation nausea 65 posaconazole 65 Eisenmenger syndrome 65 Severe Primary IGFD 65 ACTEMRA TM 65 neurologic disorder 65 delayed CINV 65 colorectal adenoma 65 Infusion Reactions Severe 65 salmeterol HFA MDI 65 hematological toxicity 65 unstable angina UA 65 conventional DMARDs 65 hepatorenal syndrome 65 Dose adjustments 65 hyperalgesia 65 kidney urologic 65 VAPRISOL 65 neurologic sequelae 65 efalizumab 65 Peripheral edema 65 pulmonary infiltrates 65 Parkinsonian symptoms 65 recurrent VTE 65 Restless Legs Syndrome RLS 65 prodromal symptoms 65 severe exacerbations 65 oral NSAIDs 65 cystic fibrosis chronic pancreatitis 65 anticholinergic medications 65 concomitant medications 65 non alcoholic steatohepatitis 65 Pseudomonas aeruginosa infections 65 lumbar spinal stenosis LSS 65 mild renal insufficiency 65 KETEK 65 fibromyalgia syndrome 65 CYT# potent vascular disrupting 65 subsyndromal 65 HBV infections 65 vasogenic edema 65 neovascular 65 anaphylaxis dyspnea flushing 65 Erythropoietic therapies may 65 aneurysmal subarachnoid hemorrhage 65 interferon ribavirin 65 vWD 65 adrenal insufficiency 65 juvenile idiopathic arthritis 65 carcinoid syndrome 65 Tasimelteon 65 carotid stenosis 65 Fibrillex TM 65 hepatotoxicity 65 levodopa carbidopa 65 ATACAND 65 EFFEXOR XR 65 intravascular hemolysis 65 ribavirin therapy 65 anemia thrombocytopenia 65 sotalol 65 schizophrenia CIAS 65 opioid induced bowel dysfunction 65 neutropenia dehydration dyspnea 65 Ribavirin causes 65 myocardial ischemia 65 nonvertebral fracture 65 Cleviprex TM clevidipine 65 pancytopenia 65 heart palpitations dizziness 65 intracranial hemorrhage ICH 65 PrandiMet TM 65 TELINTRA 65 agomelatine 65 chronic metabolic acidosis 65 akinetic mutism 65 LHRH agonists 65 glomerular filtration 65 atherogenic dyslipidemia 65 genotypic resistance 65 sleep apneas 65 anticholinergic drugs 65 AGHD 65 chronic neuropathic pain 65 neurological manifestations 65 CINTREDEKIN BESUDOTOX 65 IBS C 65 relapsed MM 65 CIMZIA ™ 65 lupus erythematosus 65 RAS mutations 65 bullous 65 hypercholesterolaemia 65 ICD shocks 65 either acutely decompensated 65 diabetic neuropathic pain 65 pulmonary exacerbation 65 decompensated heart failure 65 NMDA antagonists 65 receiving VELCADE 65 clevidipine 65 curative resection 65 progressive neurodegenerative disorder 65 Non inferiority 65 QT interval prolongation 65 HeFH 64 reflux symptoms 64 potassium sparing diuretics 64 comorbid disorders 64 pheochromocytoma 64 risperidone Risperdal 64 unresectable HCC 64 analgesic medications 64 chronic GVHD 64 Toxicities 64 atrial arrhythmias 64 ALT flares 64 Cholinesterase inhibitors 64 vulvovaginal atrophy 64 pathologic fractures 64 pouchitis 64 haloperidol Haldol 64 hypophosphatemia 64 neurosensory 64 cough wheezing 64 thromboembolic events 64 generalized seizures 64 ventricular tachyarrhythmia 64 intensive statin therapy 64 neurologic deficits 64 overactive bladder syndrome 64 Myelodysplastic syndromes MDS 64 hypoglycemic episodes 64 Pulmonary arterial hypertension 64 apneic episodes 64 bowel dysfunction 64 antidiabetic medications 64 nonmelanoma skin cancers 64 included neutropenia anemia 64 isolated systolic hypertension 64 T2DM 64 prophylactic therapy 64 lipid lowering therapies 64 SILENOR 64 hematologic disorders 64 non metastatic osteosarcoma 64 gastrointestinal disturbances 64 variant angina 64 Overactive bladder 64 Navelbine ® 64 inhaled bronchodilators 64 hyperammonemia 64 diabetic peripheral neuropathy 64 myelofibrosis polycythemia vera 64 osteoporotic vertebral compression fractures 64 ziconotide 64 venlafaxine Effexor 64 G6PD deficiency 64 pharmacologic stress 64 Daytime sleepiness 64 Cognitive impairment 64 debilitating complication 64 cerebrovascular events 64 PSVT 64 QT prolongation 64 anemia neutropenia 64 homozygous familial hypercholesterolemia 64 chronic urticaria 64 candidemia 64 occlusive disease 64 nerve degeneration 64 neuropsychological impairments 64 hypomagnesemia 64 cortical excitability 64 SGPT 64 Aggrastat ® tirofiban hydrochloride 64 metabolic acidosis 64 NYHA Class II 64 claudication 64 thromboembolic disease 64 PLX STROKE targeting 64 biologic DMARD 64 neutropaenia 64 hypercalcaemia 64 visilizumab 64 choroidal vasculopathy 64 systemic corticosteroids 64 bronchial hyperresponsiveness 64 clomipramine 64 milrinone 64 transaminase levels 64 skeletal metastases 64 hypoperfusion 64 Atypical antipsychotics 64 primary dysmenorrhea 64 AGILECT ® 64 atrophic gastritis 64 nonalcoholic steatohepatitis 64 nicardipine 64 ARCALYST ® 64 oxycodone CR 64 pyrexia mucositis sepsis febrile 64 tumor necrosis 64 elevated triglyceride levels 64 levodopa induced 64 headache nasopharyngitis 64 pharmacokinetic interactions 64 syndrome OSAS 64 hyperglycaemia 64 systolic dysfunction 64 Febrile neutropenia 64 cerebral vasospasm 64 Excessive daytime sleepiness 64 neutropenia thrombocytopenia 64 PDE4 inhibitors 64 familial hypercholesterolemia FH 64 nausea vomiting headache 64 ULTRAM ER 64 pamidronate 64 heparin induced thrombocytopenia 64 acetonide FA 64 MGd 64 acromegalic patients 64 elevated serum creatinine 64 Major Depressive Disorder 64 antiemetics 64 desvenlafaxine succinate 64 warfarin therapy 64 generalized epilepsy 64 dysmenorrhoea 64 Zavesca ® 64 chronic eosinophilic leukemia 64 pulmonary hypertension PH 64 serum phosphorous 64 heavy menstrual bleeding 64 cytopenia 64 renoprotective 64 macrolide antibiotic 64 EGFR tyrosine kinase inhibitors 64 Thalomid ® 64 empiric treatment 64 squalamine 64 cardiac conduction 64 nausea constipation 64 neovascular diseases 64 Alequel 64 forodesine 64 valvular heart disease 64 PASI scores 64 benign prostatic hypertrophy 64 secondary hyperparathyroidism 64 untreated celiac disease 64 bacteriuria 64 Sleep disordered breathing 64 beta interferons 64 coagulation abnormalities 64 hepatic toxicity 64 intermittent hypoxia 64 hepatic liver 64 clinically meaningful reductions 64 antiandrogens 64 opioid bowel dysfunction 64 complement inhibitor eculizumab 64 MGUS 64 post herpetic neuralgia 64 alvimopan 64 renal flares 64 Thrombocytopenia 64 NSAID therapy 64 SYN# 64 intravesical therapy 64 intravenous cyclophosphamide 64 hematologic abnormalities 64 HIV HCV coinfected 64 Vitamin B# deficiency 64 atrioventricular block 64 conventional antipsychotics 64 hepatic enzyme 64 brivaracetam 64 dermatologic reactions 64 invasive candidiasis 64 β blocker 64 gouty arthritis 63 Raynaud syndrome 63 MULTAQ 63 DDP# 63 mycophenolate mofetil 63 systemic immunosuppressive drugs 63 mixed hyperlipidemia 63 dosage regimens 63 arterial insufficiency 63 primary Restless Legs 63 potentially hepatotoxic 63 reflux disease GERD 63 NAbs 63 generalized tonic clonic seizures 63 postoperative atrial fibrillation 63 Potiga 63 methotrexate therapy 63 obstructive sleep 63 bacterial prostatitis 63 anticholinergic effects 63 antiepileptics 63 frequent awakenings 63 cartilage degeneration 63 hepatic insufficiency 63 hypokalemia hypomagnesemia 63 cannabinor 63 perioperative morbidity 63 progressive dyspnea 63 Mood disorders 63 Relapsing remitting MS 63 myelodysplastic myeloproliferative diseases 63 chills fever headache 63 Serious adverse reactions 63 detrusor overactivity 63 Serdolect ® 63 nitrofurantoin 63 androgen excess 63 pharmacologic treatments 63 C1 INH deficiency 63 coagulopathy 63 GH deficiency 63 Enlarged prostate 63 angina pectoris 63 dermopathy 63 calcineurin inhibitor 63 varicella infection 63 concomitant antibiotics 63 prolonged QT intervals 63 SUSTENNA TM 63 resynchronization therapy 63 comorbid psychiatric 63 interstitial pneumonitis 63 erlotinib Tarceva ® 63 adalimumab Humira 63 coronary revascularization procedures 63 pancreatic insufficiency 63 gastrointestinal motility 63 plasma pharmacokinetics 63 peripheral sensory neuropathy 63 renal impairment 63 ZOLINZA 63 anticholinergic agents 63 sustained ventricular tachycardia 63 T1DM 63 pulmonary dysfunction 63 hypovolemia 63 immunosuppressive medications 63 hypoglycemic events 63 neurological disorder characterized 63 LYSTEDA 63 disk herniation 63 rheumatic disorders 63 primary hyperparathyroidism 63 primary generalized tonic 63 hypersensitivity allergic reactions 63 treat chronic sinusitis 63 metformin accumulation 63 overactive bladder OAB 63 Magnesium deficiency 63 thrombocytopenia neutropenia 63 Mitoxantrone 63 thrombotic events 63 QTc interval 63 lupus scleroderma 63 ONTAK 63 smoldering multiple myeloma 63 asymptomatic hyperuricemia 63 subclinical hypothyroidism 63 recurrent seizures 63 cervicitis 63 antiplatelet medication 63 stable angina 63 antiplatelet drugs 63 Neovascular AMD 63 AST ALT 63 anticlotting drugs 63 denileukin diftitox 63 urethritis 63 Angioedema 63 quetiapine Seroquel 63 onset seizures 63 FAMPYRA 63 Aortic stenosis 63 malabsorptive 63 Bronchiectasis 63 AA Amyloidosis 63 fluid overload 63 concomitant AEDs 63 opioid induced 63 Urge incontinence 63 immunosuppressant therapy 63 prokinetic agent 63 Oral mucositis 63 hypoparathyroidism 63 thalidomide Thalomid 63 oral antidiabetic medication 63 neurocognitive impairment 63 androgen ablation 63 alpha1 antitrypsin deficiency 63 malignant pleural effusion 63 polyarticular 63 Pulmonary hypertension 63 dyslipidemias 63 stage IIIB 63 prospectively stratified 63 prostanoid 63 headache nausea diarrhea 63 Acute Bacterial Sinusitis ABS 63 symptomatic VTE 63 inotropic 63 danazol 63 coronary insufficiency 63 postoperative complication 63 poststroke depression 63 elevated transaminases 63 sargramostim 63 Pegloticase 63 liver dysfunction 63 Diovan HCT 63 hyperparathyroidism 63 generalized anxiety disorder GAD 63 angina chest 63 Essential tremor 63 improves glycemic 63 cerebral ischemia 63 esophageal candidiasis 63 severe asthma exacerbations 63 antiplatelet therapies 63 fibrinolysis 63 EDEMA3 trial 63 circadian rhythm sleep 63 underlying pathophysiology 63 adverse cytogenetics 63 Mucositis 63 urolithiasis 63 anti angiogenic agents 63 antiepileptic 63 metastatic malignant 63 ischemic complications 63 Irritable bowel syndrome 63 renal scarring 63 serum aminotransferase levels 63 Symadex 63 anterior uveitis 63 ventricular dysfunction 63 leukoencephalopathy 63 Hydroxyurea 63 chronic pancreatitis CP 63 primary aldosteronism 63 inotropes 63 AAT deficiency 63 deep venous thromboses 63 knee osteoarthritis OA 63 hypertension diabetes mellitus 63 DACH platinum 63 neurologic dysfunction 63 daytime drowsiness 63 neutropenic patients 63 herpes zoster shingles 63 dirucotide MBP# 63 opioid induced constipation 63 eosinophilic pneumonia 63 Obstructive sleep apnea OSA 63 androgen deficiency 63 Chronic constipation 63 somnolence dizziness 63 Genetic predisposition 63 erythropoietic 63 ALT elevations 63 pericardial effusion 63 Lixivaptan 63 peripheral arterial occlusive disease 63 IGFD 63 cerebral infarction 63 left ventricular dysfunction 63 severe hypercholesterolemia 63 atrial tachyarrhythmias 63 panitumumab Vectibix 63 virologic breakthrough 63 gastrointestinal GI motility disorders 63 Opportunistic infections 63 somatostatin analogues 63 selegiline 63 gastrointestinal adverse reactions 63 treprostinil 63 hepatic enzymes 63 bezafibrate 63 EDARBI 63 invasive aspergillosis 63 thrombolytic agents 63 degenerative neurological diseases 63 psychiatric comorbidities 63 conjunctival hyperemia 63 Acute pancreatitis 63 Topiramate 63 lymphadenopathy 63 thiazide diuretic 63 antioxidant supplementation 63 neuroleptic malignant syndrome 63 mild hepatic impairment 63 thetreatment 63 thrombocytosis 63 hepatic dysfunction 63 painful diabetic neuropathy 63 nonarteritic anterior ischemic optic 63 cranial irradiation 63 constipation OIC 63 co morbidities 63 autoimmune reactions 63 upper gastrointestinal bleeding 63 aldosterone antagonist 63 glycated hemoglobin levels 63 alkalosis 63 Vimpat R 63 neuropathies 63 MYCAMINE 63 acute decompensation 63 recurrent genital herpes 63 CPAP adherence 63 postoperative ileus 63 myeloproliferative diseases 63 urinary symptoms 63 Peripheral artery disease 63 induce remission 63 ximelagatran 63 silent myocardial ischemia 63 nonmetastatic prostate cancer 63 lactic acidosis 63 cancer cachexia 63 SNT MC# 63 Lupus nephritis 63 Primary IGFD 63 herpes zoster infection 63 EBV infection 63 coadministration 63 baminercept 63 PEGINTRON TM 63 sitaxsentan 63 akinesia 63 LATUDA 63 eculizumab therapy 63 recurrent ischemia 63 aripiprazole Abilify 63 hippocampal atrophy 63 bradykinesia 63 nasal obstruction 63 divalproex sodium 63 electrolyte abnormalities 63 hematopoietic malignancies 63 EGFR inhibitors 63 Helicobacter pylori eradication 63 hematopoietic cancers 62 cardiac valvulopathy 62 VEGF inhibitors 62 hypercoagulable 62 familial adenomatous polyposis 62 nasal polyposis 62 epistaxis 62 convulsive disorders 62 inflammatory rheumatic 62 severe hypoglycaemia 62 RAPAFLO R 62 Gorlin syndrome 62 COPD exacerbation 62 LOVENOX R 62 fatigue abdominal pain 62 reduce serum phosphate 62 cardioembolic stroke 62 HPA axis suppression 62 acetabular dysplasia 62 IOP lowering 62 dopamine partial agonist 62 antiarrhythmic medications 62 tranylcypromine 62 disordered breathing 62 relapsed ALL 62 somatic complaints 62 hypertrophic scars 62 MYLOTARG 62 cabergoline 62 headache nausea dizziness 62 Lactic acidosis 62 autoimmune encephalitis 62 Hepatotoxicity 62 brain lesions 62 chronic periodontitis 62 gastrointestinal reflux 62 temporal arteritis 62 anti arrhythmic drugs 62 COREG 62 gastro oesophageal reflux 62 venlafaxine XR 62 cardiac insufficiency 62 amenorrhoea 62 somatostatin analogs 62 vitreous hemorrhage 62 ventricular arrhythmia 62 cognitive dysfunction 62 adrenalectomy 62 macular edema secondary 62 CYP#A# substrate 62 decompensated liver disease 62 Hepatocellular Carcinoma HCC 62 Zavesca R 62 transaminases 62 hyperkalemia 62 monoclonal gammopathy 62 non valvular atrial 62 subependymal giant cell 62 hypoventilation 62 ß blockers 62 Autoimmune disorders 62 isoproterenol 62 weekly subcutaneous injections 62 arterial calcification 62 aromatase inhibitors AIs 62 PROCRIT ® 62 radiculopathy 62 geographic atrophy 62 caspofungin 62 thrombophilia 62 octreotide LAR 62 asthma exacerbation 62 REMICADE ® 62 LV dysfunction 62 parkinsonism 62 antihypertensive therapies 62 oral FTY# 62 Paxil paroxetine 62 STRIDE PD 62 posterior uveitis 62 follicular lymphoma FL 62 hyperacute 62 hypokalemia 62 preserved ejection fraction 62 autoantibody levels 62 valvular disease 62 BYSTOLIC 62 myalgia arthralgia 62 anticancer treatments 62 NNT = 62 pathophysiological mechanisms 62 venous thromboembolic events 62 Deferiprone 62 hydrops 62 cardiotoxic 62 O PPDS 62 familial hypercholesterolemia 62 Thal Dex 62 ADAGIO study 62 elevated LDH 62 Chronic angina 62 cardiac toxicity 62 flecainide 62 cholinesterase inhibitor 62 anticonvulsant medications 62 albumin excretion 62 colorectal liver metastases 62 CIMZIA TM certolizumab pegol 62 CYP #A# 62 primary hypercholesterolemia 62 metastatic gastric 62 diarrhea predominant irritable 62 INCB# [003] 62 Obstructive sleep apnea 62 standard chemotherapy regimens 62 Venous thromboembolism 62 tachyarrhythmia 62 postoperative infections 62 PRADAXA 62 Gel repository corticotropin injection 62 postoperative pulmonary 62 basal cell nevus syndrome 62 hypocalcemia 62 sensory neuropathy 62 carcinoids 62 cardiac repolarization 62 FASLODEX 62 chronic prostatitis chronic 62 chronic myocardial ischemia 62 paricalcitol 62 Tolvaptan 62 clazosentan 62 airway narrowing 62 dysmotility 62 Bcr Abl mutations 62 Systemic lupus erythematosus SLE 62 oral prodrug 62 cystoid macular edema 62 aspirin clopidogrel 62 Dementia Related Psychosis 62 postsurgical pain 62 choroidal neovascularization CNV 62 asplenia 62 sorafenib tablets 62 INTEGRILIN R 62 somatic symptoms 62 HNSCC 62 anemia hemoglobin 62 Barrett esophagus BE 62 gastrointestinal dysfunction 62 BENICAR HCT 62 serum phosphate 62 INVANZ 62 dyspnoea 62 flutamide 62 allodynia 62 alpha blocker 62 GBA mutations 62 bronchodilator therapy 62 euvolemic 62 anticoagulant warfarin 62 mu opioid agonists 62 RLAI 62 dose Iluvien 62 Certolizumab pegol 62 dopamine antagonists 62 dose titration 62 indolent NHL 62 diarrhea predominant IBS 62 Mg Uk 62 Perforomist ™ Inhalation Solution 62 mecasermin 62 canakinumab 62 proctitis 62 QTc intervals 62 post herpetic 62 hypervascular tumors 62 lucinactant 62 oral anticoagulant therapy 62 Triolex 62 antidiabetic drugs 62 hemodynamically unstable 62 post operative ileus 62 hyperuricemia 62 symptomatic hypotension 62 APTIVUS ritonavir 62 anthracyclines taxanes 62 postoperative ileus POI 62 revascularization procedures 62 premenstrual dysphoric disorder PMDD 62 Gastroparesis 62 adrenal function 62 maximal doses 62 INVEGA R 62 gastroduodenal 62 immune thrombocytopenic purpura ITP 62 NAGS deficiency 62 acute hepatic 62 lung fibrosis 62 retinopathy nephropathy 62 sulphonylureas 62 Difficulty swallowing 62 ano genital warts 62 chemotherapy induced neutropenia 62 abnormal uterine bleeding 62 relapsed SCLC 62 depressive symptomatology 62 phase IIb trial 62 antithrombotic therapies 62 ARCOXIA 62 Kepivance 62 chronic hepatitis cirrhosis 62 AChE inhibitors 62 osteoarthritic 62 dysuria 62 clinically meaningful improvements 62 atypical antipsychotic medications 62 dosing frequency 62 macrovascular events 62 insulin detemir 62 adriamycin 62 pharmacologic therapies 62 verteporfin 62 antianginal 62 tapentadol ER 62 TTR amyloidosis 62 differentiated thyroid 62 grade cervical intraepithelial 62 atherothrombotic events 62 thiopurine 62 Chlamydia trachomatis infection 62 euthymic patients 62 TMJD 62 Myelosuppression 62 topical calcineurin inhibitors 62 CRVO 62 parathyroid 62 cardiovascular cerebrovascular 62 Heavy snorers 62 vesicoureteral reflux 62 ventricular remodeling 62 underdiagnosis 62 hypercalciuria 62 rebleeding 62 rituximab monotherapy 62 intracerebral hemorrhage 62 Ischemic 62 diabetes mellitus DM 62 mitochondrial toxicity 62 Prostatitis 62 MS relapses 62 sJIA 62 pharmacological therapy 62 Parnate 62 somatostatin analog 62 leukemia AML 62 liver transaminases 62 active ankylosing spondylitis 62 osteosarcomas 62 menopausal symptom 62 Candida infection 62 motor neuron degeneration 62 abnormal vaginal bleeding 62 painful menstruation 62 KAPIDEX